BioCardia, Inc.
BCDA
$1.83
-$0.04-2.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -- | -93.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -- | -93.02% |
| Cost of Revenue | 71.00% | 23.29% | -234.69% | -50.27% | -65.43% |
| Gross Profit | -71.64% | -29.01% | 236.22% | 38.55% | 64.91% |
| SG&A Expenses | -19.84% | 9.83% | -3.72% | -23.82% | -27.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.15% | 17.00% | 10.68% | -40.58% | -52.73% |
| Operating Income | -24.38% | -19.82% | -11.37% | 32.41% | 52.23% |
| Income Before Tax | -24.48% | -19.63% | -10.81% | 32.52% | 51.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.48% | -19.63% | -10.81% | 32.52% | 51.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.48% | -19.63% | -10.81% | 32.52% | 51.93% |
| EBIT | -24.38% | -19.82% | -11.37% | 32.41% | 52.23% |
| EBITDA | -25.37% | -20.30% | -11.72% | 32.48% | 52.43% |
| EPS Basic | 53.81% | 56.76% | 63.72% | 65.61% | 65.20% |
| Normalized Basic EPS | 53.82% | 56.76% | 63.72% | 65.60% | 65.19% |
| EPS Diluted | 53.81% | 56.76% | 27.27% | 65.61% | 65.20% |
| Normalized Diluted EPS | 53.82% | 56.76% | 63.72% | 65.60% | 65.19% |
| Average Basic Shares Outstanding | 169.55% | 176.68% | 205.47% | 96.22% | 38.12% |
| Average Diluted Shares Outstanding | 169.55% | 176.68% | 205.47% | 96.22% | 38.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |